Reneo Pharmaceuticals, Inc. Contracts & Agreements

Registration Rights Agreement dated October 4, 2024 by and among OnKure Therapeutics, Inc. and certain parties thereto (Filed With SEC on October 8, 2024)

Form of Indemnification Agreement (Filed With SEC on October 8, 2024)

OnKure Therapeutics, Inc. Outside Director Compensation Policy (Filed With SEC on October 8, 2024)

OnKure Therapeutics, Inc. Form of Executive Employment Agreement (Filed With SEC on October 8, 2024)

OnKure Therapeutics, Inc. Executive Incentive Compensation Plan (Filed With SEC on October 8, 2024)

OnKure, Inc. 2023 RSU Equity Incentive Plan, and forms of agreement thereunder (Filed With SEC on October 8, 2024)

OnKure, Inc. 2021 Stock Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on October 8, 2024)

OnKure, Inc. 2011 Stock Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on October 8, 2024)

OnKure Therapeutics, Inc. 2024 Employee Stock Purchase Plan (Filed With SEC on October 8, 2024)

OnKure Therapeutics, Inc. 2024 Equity Incentive Plan, and forms of agreement thereunder (Filed With SEC on October 8, 2024)

Consulting Agreement, dated May 10, 2024, by and between the Registrant and Gregory J. Flesher (Filed With SEC on August 13, 2024)

Consulting Agreement, dated May 10, 2024, by and between the Registrant and Alejandro Dorenbaum, M.D (Filed With SEC on August 13, 2024)

Consulting Agreement, dated May 10, 2024, by and between the Registrant and Ashley F. Hall, J.D (Filed With SEC on August 13, 2024)

Consulting Agreement, dated May 10, 2024, by and between the Registrant and Michael P. Cruse (Filed With SEC on August 13, 2024)

OnKure, Inc. 2023 RSU Equity Incentive Plan, and forms of agreement thereunder (Filed With SEC on June 21, 2024)

OnKure, Inc. 2021 Stock Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on June 21, 2024)

OnKure, Inc. 2011 Stock Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on June 21, 2024)

Sales Agreement, dated November 13, 2023, by and between the Registrant and Leerink Partners LLC (Filed With SEC on November 13, 2023)

Underwriting Agreement, dated as of May 3, 2023, by and among Reneo Pharmaceuticals, Inc. and Jefferies LLC, BofA Securities, Inc. and Piper Sandler & Co., as representatives of... (Filed With SEC on May 5, 2023)

Securities Purchase Agreement, dated as of May 2, 2023, by and between Reneo Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP (Filed With SEC on May 5, 2023)

Reneo Pharmaceuticals, Inc. Severance Benefit Plan, as amended as of September 27, 2022, and form of Participation Agreement thereunder (Filed With SEC on November 8, 2022)

Letter Agreement by and between the Registrant and Roshawn Blunt, dated August 2, 2022 (Filed With SEC on August 9, 2022)

Transition, Separation and Consulting Agreement by and between the Registrant and Vineet R. Jindal, dated February 2, 2022 (Filed With SEC on March 23, 2022)

Letter Agreement by and between Registrant and Paul W. Hoelscher, dated January 20, 2022 (Filed With SEC on March 23, 2022)

Transition, Separation and Consulting Agreement by and between the Registrant and Wendy Johnson, dated December 23, 2021 (Filed With SEC on March 23, 2022)

Reneo Pharmaceuticals, Inc. 2021 Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 23, 2022)

Description of Common Stock of the Registrant (Filed With SEC on March 23, 2022)

Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise for Inducement Grant Outside of the Reneo Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on November 12, 2021)

Forms of RSU Award Grant Notice and Award Agreement (RSU Award) for Inducement Grant Outside of the Reneo Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on November 12, 2021)

Reneo Pharmaceuticals, Inc. UK Sharesave Sub-Plan to the Reneo Pharmaceuticals, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on November 12, 2021)

Reneo Pharmaceuticals, Inc. Severance Benefit Plan, as amended, and form of Participation Agreement thereunder (Filed With SEC on November 12, 2021)

Employment Agreement by and between the Registrant and Ashley F. Hall, J.D., dated October 11, 2021 (Filed With SEC on November 12, 2021)

Reneo Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on April 5, 2021)

Form of Underwriting Agreement (Filed With SEC on April 5, 2021)

Form of Common Stock Certificate (Filed With SEC on April 5, 2021)

Reneo Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended, and UK Sub-Plan (Filed With SEC on April 5, 2021)

Forms of (i) Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise and (ii) Stock Option Grant Notice - International, Stock Option Agreement - International... (Filed With SEC on April 5, 2021)

Forms of (i) Restricted Stock Unit Award Grant Notice and Award Agreement and (ii) Restricted Stock Unit Award Grant Notice - International and Award Agreement - International... (Filed With SEC on April 5, 2021)

Reneo Pharmaceuticals, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on April 5, 2021)

Reneo Pharmaceuticals, Inc. 2021 Non-Employee Director Compensation Policy (Filed With SEC on April 5, 2021)

Reneo Pharmaceuticals, Inc. Severance Benefit Plan and form of Participation Agreement thereunder (Filed With SEC on April 5, 2021)

Employment Agreement by and between the Registrant and Vineet R. Jindal, dated March 16, 2021 (Filed With SEC on April 5, 2021)

Reneo Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended, and UK Sub-Plan (Filed With SEC on March 19, 2021)

Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated December 9, 2020 (Filed With SEC on March 19, 2021)

Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the Reneo Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended, and UK Sub-Plan (Filed With SEC on March 19, 2021)

Form of Indemnity Agreement by and between the Registrant and its directors and executive officers (Filed With SEC on March 19, 2021)

Reneo Pharmaceuticals, Inc. Severance Benefit Plan and form of Participation Agreement thereunder (Filed With SEC on March 19, 2021)

Employment Agreement by and between the Registrant and Gregory J. Flesher, dated November 2, 2020 (Filed With SEC on March 19, 2021)

Letter Agreement by and between the Registrant and Niall ODonnell, Ph.D., dated February 1, 2018 (Filed With SEC on March 19, 2021)

Employment Agreement by and between the Registrant and Wendy Johnson, dated February 1, 2018 (Filed With SEC on March 19, 2021)

Employment Agreement by and between the Registrant and Alejandro Dorenbaum, M.D., dated January 1, 2018 (Filed With SEC on March 19, 2021)

Employment Agreement by and between the Registrant and Michael Cruse, dated November 20, 2020 (Filed With SEC on March 19, 2021)

Employment Agreement by and between the Registrant and Vineet R. Jindal, dated March 19, 2021 (Filed With SEC on March 19, 2021)

Letter Agreement by and between the Registrant and Michael Grey, dated February 12, 2018, as amended on December 7, 2020 (Filed With SEC on March 19, 2021)

License Agreement by and between the Registrant and vTv Therapeutics LLC, dated December 21, 2017 (Filed With SEC on March 19, 2021)

Letter Agreement by and between the Registrant and Lon Cardon, Ph.D., dated January 30, 2019 (Filed With SEC on March 19, 2021)

Letter Agreement by and between the Registrant and Eric M. Dube, Ph.D., dated March 10, 2021 (Filed With SEC on March 19, 2021)

Category

Industry

Companies

Contracts

Reneo Pharmaceuticals, Inc. Contracts & Agreements